ES5 RIMONABANT FOR THE TREATMENT OF OVERWEIGHT AND OBESE INDIVIDUALS AT INCREASED CARDIOMETABOLIC RISK-AN ECONOMIC EVALUATION USING DISCRETE EVENT SIMULATION
Abstract
Authors
D Getsios J Moller KJ Ishak P McEwan A Danel JJ Caro